Formulated for solutions. For success. For you.

A successful technology transfer normally includes review of the formulation, master manufacturing record, raw materials, process parameters, analytical methods, specifications, stability data, packaging components and regulatory commitments. The receiving CDMO then translates that knowledge into its equipment and quality system before validation and commercial production. 

Yes. Formulated Solutions supports technology transfers of established commercial products into its U.S. manufacturing network, including assessment, process transfer, analytical transfer, scale-up, validation, packaging and ongoing commercial supply.

Yes. Existing products can be transferred from overseas or domestic manufacturing operations into qualified U.S. facilities. Formulated Solutions operates manufacturing sites in Largo, Florida and Cleveland, Tennessee and can evaluate products for transfer into its U.S. network.

Typical information includes the formulation, annual volumes, batch size, manufacturing process, equipment requirements, analytical methods, specifications, stability information, packaging configuration, regulatory status and expected timing.

Yes. Formulated Solutions integrates formulation and process development so manufacturability is considered during development rather than only after a formula is complete. Programs can progress from proof of concept and pilot production through commercial-scale manufacturing.

Yes. Formulated Solutions supports appropriate non-sterile Rx programs from development and clinical or bridging supply through scale-up and commercial production.

Formulated Solutions’ technical teams work on challenging formulations, processes and delivery systems. Its combination of formulation science, process development, packaging engineering, analytical capabilities and commercial manufacturing allows problems to be evaluated as an integrated system rather than as isolated formulation or manufacturing issues.

Yes. Formulated Solutions can evaluate transfers of development-stage and commercial products from sponsors or other CDMOs. A transfer may include documentation review, analytical method transfer, engineering batches, and process validation, depending on the program.

Timing depends on the completeness of the technical package, method transfer, equipment fit, product complexity, and any regulatory filing needed for the site change. Formulated Solutions develops a milestone-based timeline for each program.
This builds on the current site’s general timeline answer; don’t publish a fixed 6–9 month estimate unless the team confirms it.

A transfer package typically includes the master batch record, formulation and specifications, analytical methods and validation reports, stability data, and process history, including known deviations. The required documents depend on the product and transfer scope.

Formulated Solutions supports programs from early clinical supply through later-stage development and commercial manufacturing. Confirm the exact phase range and project fit with the team before publication.

Batch size depends on the product, process, equipment, and program stage. Formulated Solutions can assess clinical, pilot, and commercial requirements for each project.
Add a specific range only after Operations confirms the figures and units.

Scale-up evaluates critical process parameters—such as mixing, temperature, and shear—rather than relying on batch volume alone. Pilot or engineering work can help establish that the process consistently meets product requirements before validation.

Yes. Process validation follows a lifecycle approach that includes process design, process performance qualification, and continued process verification, as applicable to the program.

Development may need to address API solubility or suspension, physical and chemical stability, rheology, dose consistency, foam performance, and compatibility with the dispensing system. The priorities depend on the product and its goals.

Ingredients and manufacturing conditions can affect a foam’s structure, texture, and dispensing performance. Formulation and process development may evaluate variables such as ingredient order, temperature, homogenization, and rheology controls.